Volume 64, Pages S27-S32 (October 2003)

Slides:



Advertisements
Similar presentations
Volume 54, Pages S135-S139 (December 1998)
Advertisements

Volume 62, Pages S12-S22 (December 2002)
Volume 59, Issue 6, Pages (June 2001)
Tiffany Shao, Jordan Weinstein, Serge Jothy, Marc Goldstein 
Osteopontin expression in acute renal allograft rejection
Volume 53, Issue 4, Pages (April 1998)
G.-T. Shin, D.R. Kim, J.-E. Lim, H. Yim, H. Kim  Kidney International 
Volume 65, Issue 2, Pages (February 2004)
Volume 68, Issue 5, Pages (November 2005)
Volume 61, Issue 3, Pages (March 2002)
Progression of renal failure and hypertensive nephrosclerosis
Sayu Omori, Ryuji Fukuzawa, Mariko Hida, Midori Awazu 
Volume 67, Issue 2, Pages (February 2005)
Hyperlipidemia aggravates renal disease in B6.ROP Os/+ mice
Epidermal growth factor receptor inhibition attenuates early kidney enlargement in experimental diabetes  Lesley Wassef, Darren J. Kelly, Richard E. Gilbert 
Volume 67, Issue 1, Pages (January 2005)
Volume 57, Issue 6, Pages (June 2000)
JAK/STAT signaling in renal diseases
Vitamin E treatment of experimental glomerular disease in rats
Volume 65, Issue 6, Pages (June 2004)
Volume 68, Issue 3, Pages (September 2005)
Endothelin A receptor blockade improves regression of flow-induced pulmonary vasculopathy in piglets  Olaf Mercier, MD, Edouard Sage, MD, Mohammed Izziki,
Volume 67, Issue 6, Pages (June 2005)
Effects of antihypertensive therapy on intrarenal angiotensin and bradykinin levels in experimental renal insufficiency  Fiona E. Mackie, Timothy W. Meyer,
Volume 74, Pages S55-S59 (December 2008)
Volume 64, Pages S46-S51 (October 2003)
Hepatocyte growth factor suppresses interstitial fibrosis in a mouse model of obstructive nephropathy  Shinya Mizuno, Kunio Matsumoto, Toshikazu Nakamura 
Volume 58, Issue 6, Pages (December 2000)
Volume 67, Issue 1, Pages (January 2005)
Volume 63, Issue 5, Pages (May 2003)
Tight blood pressure control decreases apoptosis during renal damage
Reciprocal functions of hepatocyte growth factor and transforming growth factor-β1 in the progression of renal diseases: A role for CD44?  Sandrine Florquin,
Volume 63, Issue 5, Pages (May 2003)
Volume 68, Issue 6, Pages (December 2005)
Edmund G. Lowrie  Kidney International 
Immunoglobulin light chains in uremia
Hypertension promotes integrin expression and reactive oxygen species generation by circulating leukocytes  Choong H. Kim, Nosratola D. Vaziri  Kidney.
Volume 59, Issue 2, Pages (February 2001)
Akira Shimizu, Kazuhiko Yamada, David H. Sachs, Robert B. Colvin 
Blockade of NFκB activation and renal inflammation by ultrasound-mediated gene transfer of Smad7 in rat remnant kidney  Yee-Yung Ng, Chun-Cheng Hou, Wansheng.
Volume 65, Issue 5, Pages (May 2004)
Genetic deficiency of adiponectin protects against acute kidney injury
Volume 68, Issue 6, Pages (December 2005)
Volume 78, Issue 8, Pages (October 2010)
Impact of gender on the renal response to angiotensin II
Volume 59, Issue 5, Pages (May 2001)
Volume 64, Pages S33-S38 (October 2003)
Volume 63, Issue 3, Pages (March 2003)
Volume 64, Pages S21-S26 (October 2003)
Volume 63, Issue 5, Pages (May 2003)
Protective actions of administered mesenchymal stem cells in acute kidney injury: relevance to clinical trials  Christof Westenfelder, Florian E. Togel 
Tubulointerstitial damage and progression of renal failure
Volume 68, Issue 4, Pages (October 2005)
Neurogenic factors and hypertension in renal disease
Volume 54, Pages S36-S40 (December 1998)
Volume 54, Pages S135-S139 (December 1998)
Circadian regulation of renal function
Why is proteinuria an ominous biomarker of progressive kidney disease?
Volume 62, Issue 3, Pages (September 2002)
Volume 58, Issue 4, Pages (October 2000)
Molecular mechanisms of renal hypertrophy: Role of p27Kip1
Zoltán Benyó, Christoph Görlach, Michael Wahl  Kidney International 
Effect of lipid-lowering strategies on tubular cell biology
Charles A. Herzog  Kidney International 
Volume 62, Pages S36-S41 (December 2002)
Volume 70, Issue 3, Pages (August 2006)
Role of immunocompetent cells in nonimmune renal diseases
Does an apple a day put hypertension in play?
T cells and T-cell receptors in acute renal failure
Volume 62, Pages S2-S7 (December 2002)
Presentation transcript:

Volume 64, Pages S27-S32 (October 2003) Apoptosis and NFκB activation are simultaneously induced in renal tubulointerstitium in experimental hypertension  Yasmir Quiroz, Janaury Bravo, Jaime Herrera-Acosta, Richard J. Johnson, Bernardo Rodríguez-Iturbe  Kidney International  Volume 64, Pages S27-S32 (October 2003) DOI: 10.1046/j.1523-1755.64.s86.6.x Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 1 After 2 weeks of angiotensin II (Ang II) infusion (black bar) and 3 weeks of Nω-nitro-L-arginine-methyl-ester (L-NAME) administration (gray bar), the blood pressure is significantly elevated. Values are mean ± SD. ***P < 0.001. Kidney International 2003 64, S27-S32DOI: (10.1046/j.1523-1755.64.s86.6.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 2 Superoxide-positive cells in tubulointerstitial areas of rats of angiotensin II (Ang II) group (black bar), Nω-nitro-L-arginine-methyl-ester (L-NAME) group (gray bar), and control (open bar). Values are mean ± SD. ***P < 0.001. Kidney International 2003 64, S27-S32DOI: (10.1046/j.1523-1755.64.s86.6.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 3 Apoptosis [terminal deoxynucleotidyl transferase-mediated uridine triphosphate nick-end labeling (TUNEL)-positive cells/mm2]) (open bar) and proliferating cells [proliferating cell nuclear antigen (PCNA)-positive cells/mm2] (black bar) in tubulointerstitial areas in control, angiotensin II (Ang II) group, and Nω-nitro-L-arginine-methyl-ester (L-NAME) group.***P < 0.001 for all data in the corresponding group vs. the control group. Kidney International 2003 64, S27-S32DOI: (10.1046/j.1523-1755.64.s86.6.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 4 Tubulointerstitial activation of nuclear factor kappa B (NFκB), represented as cells positive for the 65p subunit per mm2 (open bars), and accumulation of lymphocytes (CD5-positive cells/mm2) (black bars) and macrophages (ED1-positive cells/mm2) (striped bars) in experimental angiotensin II (Ang II) group, Nω-nitro-L-arginine-methyl-ester (L-NAME) group and control group. Values are mean ± SD. ***P < 0.001 for all the data in each group vs. control group. Kidney International 2003 64, S27-S32DOI: (10.1046/j.1523-1755.64.s86.6.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 5 Relationship (r = 0.835,P < 0.001) between the expression of p65 nuclear factor kappa B (NFκB) and macrophage infiltration (ED1-positive cells. Control group (open circles); angiotensin II (Ang II) (black squares); Nω-nitro-L-arginine-methyl-ester (L-NAME) group (black circles). Kidney International 2003 64, S27-S32DOI: (10.1046/j.1523-1755.64.s86.6.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 6 Microphotographs showing apoptosis [terminal deoxynucleotidyl transferase-mediated uridine triphosphate nick-end labeling (TUNEL)-positive cells (A and B), proliferating cells [proliferating cell nuclear antigen (PCNA)-positive cells] (C and D), and activated nuclear factor kappa B (NFκB) (p65-positive cells) (E and F) in biopsies from the control (A, C, and E) and experimental group (B, D, and F). Kidney International 2003 64, S27-S32DOI: (10.1046/j.1523-1755.64.s86.6.x) Copyright © 2003 International Society of Nephrology Terms and Conditions